Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma’s Board of Directors

Los Angeles, March 10, 2014 –Targeted Medical Pharma, Inc. (OTCQB:TRGM) today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company’s board of directors. A nationally respected expert in healthcare, medical and hospital administration in Australia, Dr. Wenkart established Macquarie Health Corporation in Sydney, Australia in 1976. His organization owns and operates eleven private hospitals in Australia, and is one of the nation’s leading providers of healthcare services. Dr. Wenkart is a graduate of the Sydney University School Continue reading →

Targeted Medical Pharma Launches E-Prescribe Platform for Theramine®

Improving Provider and Patient Access to Safe and Effective Pain Medications Los Angeles, CA, March 4, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced today the launch of a new e-prescribing platform for the medical food, Theramine. The secure online e-prescribing portal is available to healthcare providers in the United States, interested in a clinically validated, peer reviewed, non-pharmacologic alternative to narcotic and NSAID pain medications for patients suffering from pain syndromes. Theramine is a medical food indicated for the dietary management of pain Continue reading →

Targeted Medical Pharma Completes Promotion and Distribution Agreement for Clearwayz™

Promotion in Several Major Markets Using Direct-Response Commercials Los Angeles, CA, February 11, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), reported today on the completion of a promotion and distribution agreement with As Seen on TV Productions, a division of East Shore Enterprises, a company which specializes in brand promotion  using Direct-Response television commercials and internet promotion for select audiences in major markets. The non-exclusive agreement provides a platform for Clearwayz, to connect to a wider consumer base through online and television advertising. Clearwayz Continue reading →

Targeted Medical Pharma Selected as one of the “Best Six Stocks” by Wall-Street.com

Recognizing Growth and Market Potential in the Microcap Space  Los Angeles, January 27, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) announced today that is has been selected as one of the best six stocks in the microcap space by industry specialist Wall-Street.com, a division of Wall-Street Media Co. “We have worked very hard to be in a position to gain this type of recognition, and it is an honor to be chosen as one of the best six stocks by the industry specialist Wall-Street.com,” Continue reading →

Targeted Medical Pharma Announces Completion of Sales Agreement with Pacific Medical, Inc

Agreement Provides the Company with the Ability to Rapidly Expand Sales and Education Programs Los Angeles, CA, January 10, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), reported on the completion of an independent sales agreement with Pacific Medical, Inc., a distributor of durable medical equipment in the United States who specializes in orthopedic, rehabilitation, surgery and sports medicine. The non-exclusive agreement will allow Targeted Medical Pharma to expand medical food sales and education programs to licensed healthcare professionals in Northern California and Northern Nevada Continue reading →

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase Los Angeles, January 9, 2014 — Targeted Medical Pharma, announced that members of its executive team are scheduled to present the latest information regarding medical foods at the sixth annual Biotech Showcase™ on January 14, 2014 at 4:00 p.m. PST, at the Parc 55 Wyndham Hotel in San Francisco, CA. Management also will conduct one-on-one meetings with investors from January 13-15, 2014. Biotech Showcase is an investor and partnering conference devoted to providing private Continue reading →

Targeted Medical Pharma Reports Initial Results from a Clinical Observation of Medical Foods for Children and Adults with Autistic Spectrum Disorder Symptoms

Addressing the Nutrient Deficiencies Associated with Autism Spectrum Disorders for both Children and Adults Los Angeles, CA, December 23, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced additional preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children and young adults with autism spectrum disease (ASD) symptoms. 34 subjects including 29 children and 5 young adults ages seven to twenty-one who were diagnosed with ASD or suffering from related symptoms including explosive behavior, Continue reading →

Targeted Medical Pharma Senior Management Buys Stock and Converts Loans to Equity

17,780 Shares Purchased on the Open Market and $1,000,000 Loan Converted to Stock Los Angeles, CA, December 18, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced that senior management has purchased 17,780 shares of the Company’s stock in the open market during the fourth quarter of 2013. In addition, Company CEO William Shell, M.D. also converted $1,000,000 in loans, which were made to the company in 2011 to fund production growth, into TRGM common stock. “The purchase of shares and conversion of loans Continue reading →

Targeted Medical Pharma to Present at 6th Annual LD Micro Growth Conference

Los Angeles, December 4, 2013 – Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the LD Micro Growth Conference on December 5, 2012 at 1:30 p.m. Pacific Time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. About Targeted Medical Pharma, Inc. Targeted Medical Pharma, Inc., is a Los Angeles-based biotechnology company that develops  medical foods for the treatment of chronic disease, including Continue reading →

Targeted Medical Pharma Reports 2013 Third Quarter Financial Results

Year-Over-Year Revenue Increase of 41% and Gross Profit Increase of 84% for the nine months ended September 30, 2013  Los Angeles, CA, November 15, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced financial results for its third quarter ended September 30, 2013.  The Company posted increased revenues, gross profit and a reduction in net loss before interest, taxes, depreciation and amortization, stock based compensation, and non-recurring expenses (Adjusted EBITDA) on both a year-over-year and a quarterly basis. Financial Overview Year-over-Year Comparison: Improved financial results for Continue reading →